TipRanks
Charles River Laboratories Intl (CH:RV6)
:RV6
Switzerland Market
RV6
Charles River Labs
RESEARCH TOOLSreports

Charles River Labs (RV6) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

RV6 Analyst Ratings

Strong Buy
16Ratings
Strong Buy
14 Buy
2 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Charles
River Labs
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RV6 Stock 12 Month Forecast

Average Price Target

―
Based on 16 Wall Street analysts offering 12 month price targets for Charles River Labs in the last 3 months. The average price target is CHF264.98 with a high forecast of CHF296.14 and a low forecast of CHF181.67. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF296.14Average Price TargetCHF264.98Lowest Price TargetCHF181.67
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:RV6
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
CHF248.86→CHF282.04
Buy
―
Reiterated
10/12/26
Charles River price target raised to $340 from $300 at Morgan StanleyCharles River price target raised to $340 from $300 at Morgan Stanley
RBC Capital Analyst forecast on CH:RV6
Ryan Halsted
RBC Capital
RBC Capital
CHF267.11
Buy
―
Reiterated
10/06/26
RBC Capital Remains a Buy on Charles River Labs (CRL)
UBS Analyst forecast on CH:RV6
Kevin Caliendo
UBS
UBS
CHF296.14
Buy
―
Initiated
09/30/26
Charles River resumed with a Buy at UBSCharles River resumed with a Buy at UBS
Jefferies Analyst forecast on CH:RV6
David Windley
Jefferies
Jefferies
CHF253.01→CHF282.04
Buy
―
Reiterated
09/28/26
Charles River price target raised to $340 from $305 at JefferiesCharles River price target raised to $340 from $305 at Jefferies
Bank of America Securities Analyst forecast on CH:RV6
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
09/28/26
Charles River price target raised to $330 from $300 at BofACharles River price target raised to $330 from $300 at BofA
Mizuho Securities Analyst forecast on CH:RV6
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF219→CHF244.71
Hold
―
Reiterated
09/25/26
Charles River price target raised to $295 from $264 at MizuhoCharles River price target raised to $295 from $264 at Mizuho
Robert W. Baird Analyst forecast on CH:RV6
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF241.39→CHF277.06
Buy
―
Reiterated
09/25/26
Charles River price target raised to $334 from $291 at BairdCharles River price target raised to $334 from $291 at Baird
TD Cowen Analyst forecast on CH:RV6
Charles Rhyee
TD Cowen
TD Cowen
CHF248.86→CHF269.6
Buy
―
Assigned
09/25/26
Analyst Raises Charles River Labs Price Target to $325 on Long-Term Growth and Margin Upside
Evercore ISI Analyst forecast on CH:RV6
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF265.45→CHF273.75
Buy
―
Reiterated
09/25/26
Charles River price target raised to $330 from $320 at Evercore ISICharles River price target raised to $330 from $320 at Evercore ISI
Deutsche Bank Analyst forecast on CH:RV6
Justin Bowers
Deutsche Bank
Deutsche Bank
CHF248.86→CHF265.45
Buy
―
Assigned
09/25/26
Charles River price target raised to $320 from $300 at Deutsche BankCharles River price target raised to $320 from $300 at Deutsche Bank
Barclays Analyst forecast on CH:RV6
Luke Sergott
Barclays
Barclays
CHF248.86→CHF273.75
Buy
―
Reiterated
09/24/26
Barclays Keeps Their Buy Rating on Charles River Labs (CRL)
William Blair Analyst forecast on CH:RV6
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
09/24/26
Charles River: Streamlined Strategy, Long-Term Growth Targets, and Investor Confidence Drive Buy Rating
Stephens Analyst forecast on CH:RV6
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF265.45
Buy
―
Initiated
09/22/26
Charles River Labs (CRL) Receives a New Rating from Stephens
Argus Research Analyst forecast on CH:RV6
David Toung
Argus Research
Argus Research
CHF207.38→CHF273.75
Buy
―
Assigned
09/16/26
Analysts Offer Insights on Healthcare Companies: Charles River Labs (NYSE: CRL) and Amgen (NASDAQ: AMGN)
J.P. Morgan Analyst forecast on CH:RV6
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF149.32→CHF257.16
Buy
―
Upgraded
08/05/26
Charles River upgraded to Overweight from Neutral at JPMorganCharles River upgraded to Overweight from Neutral at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:RV6
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
CHF248.86→CHF282.04
Buy
―
Reiterated
10/12/26
Charles River price target raised to $340 from $300 at Morgan StanleyCharles River price target raised to $340 from $300 at Morgan Stanley
RBC Capital Analyst forecast on CH:RV6
Ryan Halsted
RBC Capital
RBC Capital
CHF267.11
Buy
―
Reiterated
10/06/26
RBC Capital Remains a Buy on Charles River Labs (CRL)
UBS Analyst forecast on CH:RV6
Kevin Caliendo
UBS
UBS
CHF296.14
Buy
―
Initiated
09/30/26
Charles River resumed with a Buy at UBSCharles River resumed with a Buy at UBS
Jefferies Analyst forecast on CH:RV6
David Windley
Jefferies
Jefferies
CHF253.01→CHF282.04
Buy
―
Reiterated
09/28/26
Charles River price target raised to $340 from $305 at JefferiesCharles River price target raised to $340 from $305 at Jefferies
Bank of America Securities Analyst forecast on CH:RV6
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
09/28/26
Charles River price target raised to $330 from $300 at BofACharles River price target raised to $330 from $300 at BofA
Mizuho Securities Analyst forecast on CH:RV6
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF219→CHF244.71
Hold
―
Reiterated
09/25/26
Charles River price target raised to $295 from $264 at MizuhoCharles River price target raised to $295 from $264 at Mizuho
Robert W. Baird Analyst forecast on CH:RV6
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF241.39→CHF277.06
Buy
―
Reiterated
09/25/26
Charles River price target raised to $334 from $291 at BairdCharles River price target raised to $334 from $291 at Baird
TD Cowen Analyst forecast on CH:RV6
Charles Rhyee
TD Cowen
TD Cowen
CHF248.86→CHF269.6
Buy
―
Assigned
09/25/26
Analyst Raises Charles River Labs Price Target to $325 on Long-Term Growth and Margin Upside
Evercore ISI Analyst forecast on CH:RV6
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF265.45→CHF273.75
Buy
―
Reiterated
09/25/26
Charles River price target raised to $330 from $320 at Evercore ISICharles River price target raised to $330 from $320 at Evercore ISI
Deutsche Bank Analyst forecast on CH:RV6
Justin Bowers
Deutsche Bank
Deutsche Bank
CHF248.86→CHF265.45
Buy
―
Assigned
09/25/26
Charles River price target raised to $320 from $300 at Deutsche BankCharles River price target raised to $320 from $300 at Deutsche Bank
Barclays Analyst forecast on CH:RV6
Luke Sergott
Barclays
Barclays
CHF248.86→CHF273.75
Buy
―
Reiterated
09/24/26
Barclays Keeps Their Buy Rating on Charles River Labs (CRL)
William Blair Analyst forecast on CH:RV6
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
09/24/26
Charles River: Streamlined Strategy, Long-Term Growth Targets, and Investor Confidence Drive Buy Rating
Stephens Analyst forecast on CH:RV6
Unknown Analyst
Stephens
Not Ranked
Stephens
CHF265.45
Buy
―
Initiated
09/22/26
Charles River Labs (CRL) Receives a New Rating from Stephens
Argus Research Analyst forecast on CH:RV6
David Toung
Argus Research
Argus Research
CHF207.38→CHF273.75
Buy
―
Assigned
09/16/26
Analysts Offer Insights on Healthcare Companies: Charles River Labs (NYSE: CRL) and Amgen (NASDAQ: AMGN)
J.P. Morgan Analyst forecast on CH:RV6
Casey Woodring
J.P. Morgan
J.P. Morgan
CHF149.32→CHF257.16
Buy
―
Upgraded
08/05/26
Charles River upgraded to Overweight from Neutral at JPMorganCharles River upgraded to Overweight from Neutral at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
ASNDAscendis Pharma
AORTArtivion
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Charles River Labs

3 Months
David WindleyJefferies
Success Rate
26/44 ratings generated profit
59%
Average Return
+4.73%
Copying David Windley's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +4.73% per trade.
1 Year
David WindleyJefferies
Success Rate
35/44 ratings generated profit
80%
Average Return
+18.38%
Copying David Windley's trades and holding each position for 1 Year would result in 79.55% of your transactions generating a profit, with an average return of +18.38% per trade.
2 Years
David WindleyJefferies
Success Rate
35/44 ratings generated profit
80%
Average Return
+24.75%
Copying David Windley's trades and holding each position for 2 Years would result in 79.55% of your transactions generating a profit, with an average return of +24.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RV6 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
19
19
19
29
28
Hold
4
5
4
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
24
23
33
30
In the current month, RV6 has received 28 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. RV6 average Analyst price target in the past 3 months is 264.98.
Each month's total comprises the sum of three months' worth of ratings.

RV6 Financial Forecast

RV6 Earnings Forecast

Next quarter’s earnings estimate for RV6 is CHF2.47 with a range of CHF2.43 to CHF2.57. The previous quarter’s EPS was CHF2.52. RV6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RV6 has Performed in-line its overall industry.
Next quarter’s earnings estimate for RV6 is CHF2.47 with a range of CHF2.43 to CHF2.57. The previous quarter’s EPS was CHF2.52. RV6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year RV6 has Performed in-line its overall industry.

RV6 Sales Forecast

Next quarter’s sales forecast for RV6 is CHF799.93M with a range of CHF792.69M to CHF820.11M. The previous quarter’s sales results were CHF836.67M. RV6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RV6 has Performed in-line its overall industry.
Next quarter’s sales forecast for RV6 is CHF799.93M with a range of CHF792.69M to CHF820.11M. The previous quarter’s sales results were CHF836.67M. RV6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year RV6 has Performed in-line its overall industry.

RV6 Stock Forecast FAQ

What is CH:RV6’s average 12-month price target, according to analysts?
Based on analyst ratings, Charles River Laboratories Intl’s 12-month average price target is 264.98.
    What is CH:RV6’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:RV6, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Charles River Laboratories Intl a Buy, Sell or Hold?
        Charles River Laboratories Intl has a consensus rating of Strong Buy, which is based on 14 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Charles River Laboratories Intl’s share price target?
          The average share price target for Charles River Laboratories Intl is 264.98. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF296.14 ,and the lowest forecast is CHF181.67. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Charles River Laboratories Intl?
            Charles River Laboratories Intl’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of Charles River Laboratories Intl?
              To buy shares of CH:RV6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.